COVID
Conditions
Brief summary
Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.
Interventions
OTHERProspective oberservational registry
Non interventional study.
Sponsors
Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz
IHF GmbH - Institut für Herzinfarktforschung
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* In-patients fulfilling the following criteria: SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study
Exclusion criteria
* No explicit medical
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lab parameters | throughout study completion, in average 1.5 years | number of patients with significant changes in lab parameters |
| Intra-hospital complications | throughout study completion, in average 1.5 years | number of patients with complications during hospital stay |
| Vital status at discharge | throughout study completion, in average 1.5 years | vital status at discharge: alive, dead |
| Chest CT | throughout study completion, in average 1.5 years | presence of infiltrates |
| Supportive care - ICU | throughout study completion, in average 1.5 years | number of patients with ICU treatment required |
| Supportive care - oxygen therapy | throughout study completion, in average 1.5 years | number of patients with oxygen therapy required |
| Supportive care - ventilation | throughout study completion, in average 1.5 years | number of patients with ventilation required |
| Medication | throughout study completion, in average 1.5 years | number of patients with medication changes |
| Therapeutic strategies | throughout study completion, in average 1.5 years | number of patients with ECMO required |
| Chest x-ray | throughout study completion, in average 1.5 years | presence of infiltrates |
Countries
Germany
Outcome results
None listed